These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Author: Baldwin D, Bullock T, Montgomery D, Montgomery S.
    Journal: Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632.
    Abstract:
    Antidepressant drugs undoubtedly reduce much of the morbidity and mortality associated with a variety of depressive disorders. Certain types of antidepressant drugs have been shown to exert a relative advantage in the reduction of suicidal thoughts, and it is interesting that recent reports have noted an association between the prescription of some antidepressants and the development of suicidal and aggressive thoughts and behaviour. An analysis of the data from double-blind controlled trials of fluvoxamine, fluoxetine and paroxetine indicates that 5-HT uptake inhibitors exercise some protective effects on the emergence of suicidal thoughts, whereas the data from the studies with maprotiline show an increase in suicidal thoughts compared with placebo.
    [Abstract] [Full Text] [Related] [New Search]